Cinctive Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.7M Buy
41,948
+7,280
+21% +$1.7M 0.39% 72
2026
Q1
$8.47M Buy
+34,668
New +$8.08M 0.55% 53
2025
Q4
Sell
-2,904
Closed -$538K 458
2025
Q3
$538K Buy
+2,904
New +$498K 0.03% 342
2024
Q1
Sell
-18,513
Closed -$2.9M 455
2023
Q4
$2.9M Buy
+18,513
New +$2.84M 0.19% 151
2023
Q1
Sell
-1,176
Closed -$208K 466
2022
Q4
$208K Buy
+1,176
New +$203K 0.01% 352
2022
Q3
Sell
-129,853
Closed -$23.1M 537
2022
Q2
$23.1M Buy
+129,853
New +$23.1M 0.97% 11
2020
Q1
Sell
-43,631
Closed -$6.36M 241
2019
Q4
$6.36M Buy
+43,631
New +$5.92M 0.67% 47

Other funds holding JNJ

Cinctive Capital Management's JNJ Position: Q2 2026 in Review

Cinctive Capital Management increased its Johnson & Johnson (JNJ) stake by 21% in Q2 2026, buying an estimated $1.7M and bringing the position to 41,948 shares worth $10.7M. The position accounts for 0.39% of the portfolio, ranked #72.

Cinctive Capital Management first reported a position in JNJ in Q4 2019 and has held it in 7 quarters since. The position peaked at $23.1M in Q2 2022. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Cinctive Capital Management held 41,948 shares of Johnson & Johnson worth $10.7M as of Q2 2026.
  • Cinctive Capital Management bought 7,280 Johnson & Johnson shares in Q2 2026, an estimated $1.7M.
  • Johnson & Johnson made up 0.39% of Cinctive Capital Management's portfolio in Q2 2026, its #72 holding.
  • Cinctive Capital Management first reported a position in Johnson & Johnson in Q4 2019 and has held it in 7 quarters since.
  • Cinctive Capital Management's Johnson & Johnson position peaked at $23.1M in Q2 2022.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.